You are here: Industry Insights > COVID-19

News List

Ministry of Health publishes draft New Drugs and Clinical Trials (Amendment) Rules expresspharma
June 08, 2020
The move is aimed at facilitating the availability of new drugs which are in Phase-III clinical trials (human trials) for severely-ill COVID-19 patients in the country.
Fujifilm says COVID-19 drug research may drag on into July expresspharma
June 08, 2020
“There is a possibility that clinical trials will continue in July,” a Fujifilm spokesman said, responding to a Nikkei report that any approval will be delayed until July or later, due to a lack of patients for trials.
Ethypharm and RSSL Fast-Track Medicine for COVID-19 Patients contractpharma
June 05, 2020
Collaborate to accelerate the manufacture and batch release of fentanyl injection.
FSD Pharma gets FDA nod to design Covid-19 trial with ultramicronised PEA pharmaceutical-business-review
June 05, 2020
FSD Pharma has secured approval from the US Food and Drug Administration (FDA) to design a phase 2a clinical trial to evaluate the efficacy of FSD-201 ...
Scientists aim gene-targeting breakthrough against COVID-19 worldpharmanews
June 05, 2020
A team of scientists from Stanford University is working with researchers at the Molecular Foundry.
AgeX Therapeutics, ImStem Biotechnology sign non-binding letter of intent regarding investigational pharmaceutical-business-review
June 05, 2020
AgeX Therapeutics and ImStem Biotechnology, Inc. announced their signing of a non-binding letter of intent for ImStem to obtain from AgeX a non-exclusive license to use AgeX’s embryonic stem cell line ESI 053 to use AgeX’s embryonic stem cell ...
CTI BioPharma Announces Enrollment of First Patient in COVID-19 Trial americanpharmaceuticalreview
June 05, 2020
CTI BioPharma has enrolled the first patient in the Phase 3 PRE-VENT trial (NCT04404361) of pacritinib in hospitalized patients with severe COVID-19.
Proteostasis Announces In Vitro Data for Potential COVID-19 Treatment Candidate americanpharmaceuticalreview
June 05, 2020
Proteostasis Therapeutics announced results from in vitro studies evaluating the use of PTI-129 as a treatment for COVID-19.
Interim analysis indicates Auxora? is effective in severe COVID-19 pneumonia patients europeanpharmaceuticalreview
June 05, 2020
Interim results showed Auxora plus standard of care improved time to recovery and reduced ventilator use in patients compared to standard of care alone.
Lilly launches Phase I trial of investigational COVID-19 antibody treatment europeanpharmaceuticalreview
June 05, 2020
The enterprise announced the initiation of the LY-CoV555 COVID-19 antibody treatment trial at medical centres across the US.